VidjilNet Consortium
Gathering onco-hematological laboratories, research centers, and industrial and institutional partners, the VidjilNet consortium is dedicated to
- sustain and support open-source development of the Vidjil web platform, the underlying Vidjil-algo component, and possibly other software to study immune repertoires, by adapting them to the needs of members;
- provide bioinformatics support and services to the members for these software, whether for clinical purpose or for hematological or immunological research. As of 2022, the consortium provides support to host, maintain, and certify Vidjil analyses.
The consortium works into a quality approach concerning both software development and testing, the relationship with its members, and ethics on health data processing.
VidjilNet is incubated in Inria since 2018, and membership is offered since the end of 2019.
Why join the consortium?
- show your interest in the Vidjil platform, deciding collectively on its major developments and participating in the membership community, both on the user side and on the developer side;
- benefit from member-only services: installation, training and support by a bioinformatician engineer, development of functionalities, remote maintenance of a server or hosting on a shared server, transfer of data and backup configuration. Hospital laboratories as well as research groups who wish to support the project are welcome to join, even if they do not perform analyzes in a clinical setting. Inria can also receive donations for the VidjilNet consortium.
Request the contract and ask your questions to Florian, Marc, Mathieu, and Mikaël: contact@vidjil.net
2022 Memberships
Minimal Membership 3 000 € / year
- < 100 samples per year
- 1 user
Standard Membership (Laboratory) 10 000 € / year
- < 500 samples per year
- one group of users from a same laboratory
Shared, Industrial, or Support Membership 25 000 € / year
- < 2000 samples per year
- several users, several groups, several laboratories
Support for 150 other samples 3 000 €
Support for 1500 other samples 20 000 €
fees are before VAT
2021/22 Meetings
Open monthly meeting on Fridays
- 10:00 CET, zoom link
- 10 December
- 14 January
- 11 February
- 11 March
- 15 April
2021 General Assembly
- Monday 13 December, 16:00-18:00 CET
- 16-17 May 2022
Bilateral meetings can also be arranged.
Committees
The VidjilNet consortium is run by an Executive Committee and a Scientific and Technical Committee. Each committee gather 3 elected members, 3 represententative of the developpers, and 1 representantive of Inria.
Executive Committee
Members
- Pr Frédéric Davi (head) (La Pitié, APHP Paris)
- Pr Éric Delabesse (CHU Toulouse)
- Pr Claude Preudhomme (CHU Lille)
Developpers
Inria
Scientific and Technical Committee
Users
- Dr Nathalie Grardel (CHU Lille)
- Dr Cédric Pastoret (CHU Rennes)
- Dr Yannick Le Bris (CHU Nantes)
Developpers
- Marc Duez, Mathieu Giraud (head), Mikaël Salson
Inria
References, publications
The Vidjil methods and platform were first described in the following papers:
(algorithm) Mathieu Giraud, Mikaël Salson, Marc Duez, Céline Villenet, Sabine Quief, Aurélie Caillault, Nathalie Grardel, Christophe Roumier, Claude Preudhomme, Martin Figeac, Fast multiclonal clusterization of V(D)J recombinations from high-throughput sequencing, BMC Genomics, 15:409 (2014), doi:10.1186/1471-2164-15-409
(web application, updated algorithm, patient/experiment/sample database) Marc Duez, Mathieu Giraud, Ryan Herbert, Tatiana Rocher, Mikaël Salson, Florian Thonier, Vidjil: A web platform for analysis of high-throughput repertoire sequencing, PLOS ONE, 11(11):e0166126 (2016), doi:10.1371/journal.pone.0166126
More than 40 studies in hematology, immunology, and/or computational biology were published using the Vidjil platform, including 15+ papers involving VidjilNet developpers.